IPOGrid
0001907709
IPO filing research

vVARDIS Holding AG

Surgical & Medical Instruments & Apparatus

ipo amended NYSE F-1

vVARDIS Holding AG IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: F-1 on 2026-10-09. Current deal snapshot: exchange NYSE.

Filing Timeline

SEC EDGAR
F-1 filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Class A · Exchange NYSE · Ticker VVVV · Use of proceeds General corporate purposes, including working capital, operating expenses, and capital expenditures · Flags foreign_private_issuer, dual_class
vVARDIS Holding AG's F-1 filing outlines its upcoming IPO, focusing on a share capital reorganization involving the conversion of ordinary shares into Class A and Class B voting rights shares. The filing details pro forma financial adjustments, including reclassification of mezzanine equity into share capital and additional paid-in capital. Dilution risks for new investors are highlighted, tied to the IPO price and share structure changes. The company also addresses anti-dilution provisions for Class B preferred shareholders and lock-up agreements for insiders and major shareholders.
2026-10-09 · 0001140361-26-039234
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
vVARDIS Holding AG is preparing for its initial public offering (IPO) with underwriters Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC. The filing outlines the underwriting discounts and commissions, offering price adjustments, and lock-up agreements for insiders. The company plans to list on the NYSE under the symbol "VVVV." The offering includes restrictions on share sales for 180 days (270 days for co-founders) and provisions for share conversions and distributions under specific conditions.
2026-09-15 · 0001140361-26-036671
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
vVARDIS Holding AG, a Swiss dental care products company, continues to report significant financial challenges despite growth in assets and liabilities. The 2025 audited financials show a net loss of $56.4M, with total assets rising to $83.2M and liabilities reaching $143.5M. The company remains heavily reliant on debt financing and equity contributions, maintaining an accumulated deficit of $228.5M as of December 2025. Operational losses persist, with cash flow from operations declining to $16.3M in 2025 compared to $23.8M in 2024.
2026-08-11 · 0001140361-26-032091
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
The current DRS filing for vVARDIS Holding AG includes audited financial statements as of December 31, 2025, highlighting significant losses, high debt levels, and reliance on external financing. The company operates in the dental care products sector, primarily serving the U.S. market, and has an accumulated deficit of $228.5 million as of the latest reporting period.
2026-07-02 · 0001140361-26-027457

Recent News

No recent news stored for this issuer.